Alder BioPharmaceuticals® to Showcase 14 New Data Presentations Demonstrating Eptinezumab’s Migraine Prevention and Quality of Life Impact at American Headache Society Meeting

NEXT STORY
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
PREV STORY
Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics to Present at Stifel 2017 Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), ...

author_avatar
NASDAQ Market News

Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ:APTO) (TSX:APS), ...

author_avatar
NASDAQ Market News

Adaptive Research Appoints Mark Tsuchiyose, MD as Vice President, Clinical Affairs and Therapeutic Head, Gastroenterology, and Dhira Khosla, DO as Vice President, Strategic Clinical Partnerships, Positioning Company to Drive Continued Growth

author_avatar
NASDAQ Market News